Antibody response after one and two doses of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study
Hubert Blain, MD, PhD,1 Edouard Tuaillon MD, PhD,2 Lucie Gamon,3 Amandine Pisoni PhD,2 Stéphanie Miot MD, PhD,1 Yves Rolland MD, PhD,4 Marie-Christine Picot MD, PhD,3 Jean Bousquet MD, PhD5,6
  1. Department of Internal Medicine and Geriatrics, MUSE University, Montpellier, France.
  2. INSERM U 1058/EFS, University hospital, Montpellier, France
  3. Clinical research and epidemiology unit, University hospital, Montpellier, France
  4. Gérontopôle de Toulouse, INSERM 1027; Toulouse, France
  5. Clinical research and epidemiology unit, University hospital, Montpellier, France
  6. Department of Dermatology and Allergy, Universitätsmedizin, Berlin, Germany
  7. University hospital, Montpellier, France
Running title: Antibody level after BNT162b2 vaccine